Rob Pejchal will present new developability data on Adimab CD3 scFvs.
Noel Pauli will present an overview of Adimab's in vivo platform and its capabilities.
William Roach will share how to apply Adimab's diverse tools for novel T cell engagers.
Garrett Rappazzo will present on Adimab's approach to pHLA-targeting therapeutics.
The Adimab team will present on TCEs, developability, peptides, and more as they take the stage and chair sessions.